NSW CANNABIS MEDICINES

DRAFT PRESCRIBING GUIDANCE

 

In 2018, ACRE received funding through NSW Health’s Clinical Cannabis Medicines Program to develop practical NSW Cannabis Medicines Prescribing Guidance to provide interim information to support NSW medical practitioners in prescribing cannabis medicines to patients for conditions where cannabinoids are perceived to have some benefit.

A total of six (6) draft Prescribing Guidance documents have been developed to give interim practical information to assist NSW medical practitioners in their decision-making around prescribing and managing the use of cannabis medicines for the following indications:

• Anorexia Cachexia in Advanced Cancer
• Chemotherapy-Induced Nausea and Vomiting (CINV)
• Nausea in Palliative Care
• Dementia
• Non-Cancer Pain
• Spasticity


Through the Stakeholder Consultation, ACRE is now inviting feedback on the suitability of the draft Prescribing Guidance documents from a wide range of stakeholders who have an interest in the therapeutic use of cannabis medicines, or who anticipate using the guidance to inform their clinical practice.

 

CONSULTATION SUBMISSIONS

ACRE invites stakeholders to provide written submissions addressing either a single Prescribing Guidance document, a sub-set of, or all of the draft Prescribing Guidance documents. 

Please email written submissions (in Word format) to [email protected] by close of business on Friday 8 March 2019.

Submissions will typically be published on the ACRE website, unless specifically requested otherwise. However, ACRE retains the right to not publish submissions that contain offensive or defamatory comments, or do not fall within the scope of the consultation.

When finalised, the Prescribing Guidance documents will be published on ACRE’s website for public access. The final versions of the Prescribing Guidance documents will also be sent to all stakeholders who provided written submissions to the consultation and key NSW-based users. The Prescribing Guidance documents are intended to be dynamic documents, reviewed and updated annually and/or as new evidence emerges.

Although the Prescribing Guidance documents have been specifically developed for NSW-based medical practitioners, ACRE welcomes feedback from stakeholders based across Australia.

Full details on the Stakeholder Consultation and draft versions of the Prescribing Guidance are available for download, below.

 

CONSULTATION DOCUMENTS

 

ACRE Stakeholder Consultation Information (PDF)

 

Draft Prescribing Guidance: Prescribing Cannabis Medicines for Anorexia Cachexia in Advanced Cancer (PDF)

 

Draft Prescribing Guidance: Prescribing Cannabis Medicines Chemotherapy-Induced Nausea and Vomiting (CINV) (PDF)

 

Draft Prescribing Guidance: Prescribing Cannabis Medicines Nausea in Palliative Care (PDF)

 

Draft Prescribing Guidance: Prescribing Cannabis Medicines for the Management of Dementia (PDF)

 

Draft Prescribing Guidance: Prescribing Cannabis Medicines for Non-Cancer Pain (PDF)

 

Draft Prescribing Guidance: Prescribing Cannabis Medicines for Managing Spasticity (PDF)

 

FURTHER INFORMATION

For further information on the NSW Cannabis Medicines Prescribing Guidance consultation process, please email [email protected]

 

ACRE • All Right Reserved

Website by mudbath